U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with P

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138019 Q2 2022 POLYCARBOPHIL BUCCAL FILM 2mg Correction
138020 Q3 2022 POLYCARBOPHIL BUCCAL FILM 2mg Correction
138021 Q2 2022 POLYETHYLENE OXIDE 5000000 ORAL TABLET, EXTENDED RELEASE 284mg Correction
138022 Q3 2022 POLYETHYLENE OXIDE 5000000 ORAL TABLET, EXTENDED RELEASE 272mg Correction
138118 Q3 2022 PEPPERMINT OIL SUBLINGUAL SPRAY 0.34 mg Deletion
138119 Q3 2022 POLYETHYLENE GLYCOL 3350 ORAL TABLET, ORALLY DISINTEGRATING 1.01 mg Deletion
138120 Q3 2022 POLYETHYLENE GLYCOL 400 ORAL TABLET, COATED PARTICLES 12.50 mg 100mg Deletion
138121 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 2.80 mg Deletion
138122 Q3 2022 POLYETHYLENE OXIDE 200000 ORAL TABLET 173.99 mg 348mg Deletion
138123 Q3 2022 POLYSORBATE 20 NASAL AEROSOL, SPRAY 27.00 mg Deletion
138124 Q3 2022 POLYSTYRENE SULFONIC ACID ORAL TABLET 43.75 mg Deletion
138125 Q2 2022 PONCEAU 3R ORAL CAPSULE NA Deletion
138126 Q2 2022 PONCEAU 3R ORAL CAPSULE, EXTENDED RELEASE 0.04 mg Deletion
138127 Q2 2022 PONCEAU 3R ORAL SYRUP 0.01 mg/ 1.00 ml Deletion
138128 Q2 2022 PONCEAU 3R ORAL TABLET 117.20 mg Deletion
138129 Q2 2022 PONCEAU 3R ORAL TABLET, COATED 0.26 mg Deletion
138130 Q2 2022 PONCEAU 3R ORAL TABLET, EXTENDED RELEASE 0.30 mg Deletion
138131 Q2 2022 PONCEAU 3R ORAL WAFER 0.05 mg Deletion
138132 Q2 2022 PONCEAU 3R TOPICAL SHAMPOO 1.70 %w/w Deletion
138133 Q2 2022 PONCEAU 4R ORAL CAPSULE 0.01 mg Deletion
138134 Q2 2022 PONCEAU 4R ORAL TABLET 0.15 mg Deletion
138135 Q2 2022 PONCEAU XYLIDINE ORAL CAPSULE NA Deletion
138136 Q2 2022 PONCEAU XYLIDINE ORAL CAPSULE, EXTENDED RELEASE NA Deletion
138137 Q2 2022 PONCEAU XYLIDINE ORAL SOLUTION 0.05 mg/ 1.00 ml Deletion
138138 Q2 2022 PONCEAU XYLIDINE ORAL SYRUP 0.10 mg/ 1.00 ml Deletion
138139 Q2 2022 PONCEAU XYLIDINE ORAL TABLET 0.18 mg Deletion
138140 Q3 2022 POVIDONE K25 ORAL TABLET, MULTILAYER, EXTENDED RELEASE 1.8 mg Deletion
138141 Q3 2022 POVIDONE K30 ORAL TABLET, COATED PARTICLES 3.70 mg 30mg Deletion
138142 Q3 2022 POVIDONE K90 ORAL TABLET, COATED PARTICLES 27.60 mg 221mg Deletion
138345 Q2 2022 PARAFFIN ORAL TABLET, EXTENDED RELEASE 150.20 mg MDE Replacement
138346 Q3 2022 PARAFFIN ORAL TABLET, EXTENDED RELEASE 321mg MDE Replacement
138347 Q2 2022 PECTIN ORAL CAPSULE, EXTENDED RELEASE 5.447 mg MDE Replacement
138348 Q3 2022 PECTIN ORAL CAPSULE, EXTENDED RELEASE 5mg MDE Replacement
138349 Q2 2022 PEG-20 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 3.50 %w/w MDE Replacement
138350 Q3 2022 PEG-20 METHYL GLUCOSE SESQUISTEARATE TOPICAL CREAM, AUGMENTED 70mg MDE Replacement
138351 Q2 2022 PEPPERMINT OIL BUCCAL FILM 0.51 mg MDE Replacement
138352 Q3 2022 PEPPERMINT OIL BUCCAL FILM 1mg MDE Replacement
138353 Q2 2022 PHENOXYETHANOL TOPICAL CREAM, AUGMENTED 1.00 %w/w MDE Replacement
138354 Q3 2022 PHENOXYETHANOL TOPICAL CREAM, AUGMENTED 10mg MDE Replacement
138355 Q2 2022 POLOXAMER 124 TOPICAL GEL 0.20 %w/w MDE Replacement
138356 Q3 2022 POLOXAMER 124 TOPICAL GEL 6mg MDE Replacement
138357 Q2 2022 POLOXAMER 188 ORAL POWDER, FOR SOLUTION 25.00 mg/ 5.00 ml MDE Replacement
138358 Q3 2022 POLOXAMER 188 ORAL POWDER, FOR SOLUTION 500mg MDE Replacement
138359 Q2 2022 POLOXAMER 188 ORAL TABLET, FILM COATED 16.20 mg MDE Replacement
138360 Q3 2022 POLOXAMER 188 ORAL TABLET, FILM COATED 93mg MDE Replacement
138361 Q2 2022 POLOXAMER 407 ORAL TABLET 110.00 mg MDE Replacement
138362 Q3 2022 POLOXAMER 407 ORAL TABLET 495mg MDE Replacement
138363 Q2 2022 POLYETHYLENE GLYCOL 1450 ORAL CAPSULE, EXTENDED RELEASE 17.00 mg MDE Replacement
138364 Q3 2022 POLYETHYLENE GLYCOL 1450 ORAL CAPSULE, EXTENDED RELEASE 91mg MDE Replacement
138365 Q2 2022 POLYETHYLENE GLYCOL 1450 TOPICAL OINTMENT 43.00 %w/w MDE Replacement
138366 Q3 2022 POLYETHYLENE GLYCOL 1450 TOPICAL OINTMENT 921mg MDE Replacement
138367 Q2 2022 POLYETHYLENE GLYCOL 300 INTRAMUSCULAR SOLUTION 56.40 %w/v MDE Replacement
138368 Q3 2022 POLYETHYLENE GLYCOL 300 INTRAMUSCULAR SOLUTION 16920mg MDE Replacement
138369 Q2 2022 POLYETHYLENE GLYCOL 300 INTRAVENOUS SOLUTION 56.40 %w/v MDE Replacement
138370 Q3 2022 POLYETHYLENE GLYCOL 300 INTRAVENOUS SOLUTION 16920mg MDE Replacement
138371 Q2 2022 POLYETHYLENE GLYCOL 300 TOPICAL OINTMENT 57.00 %w/w MDE Replacement
138372 Q3 2022 POLYETHYLENE GLYCOL 300 TOPICAL OINTMENT 1114mg MDE Replacement
138373 Q2 2022 POLYETHYLENE GLYCOL 4000 ORAL SOLUTION 66.67 mg/ 1.00 ml MDE Replacement
138374 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL SOLUTION 2667mg MDE Replacement
138375 Q2 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, DELAYED RELEASE 1.00 mg MDE Replacement
138376 Q3 2022 POLYETHYLENE GLYCOL 4000 ORAL TABLET, DELAYED RELEASE 2mg MDE Replacement
138377 Q2 2022 POLYETHYLENE GLYCOL 4500 ORAL CAPSULE, EXTENDED RELEASE 10.00 mg MDE Replacement
138378 Q3 2022 POLYETHYLENE GLYCOL 4500 ORAL CAPSULE, EXTENDED RELEASE 53mg MDE Replacement
138379 Q2 2022 POLYISOBUTYLENE (1100000 MW) TRANSDERMAL SYSTEM 22.65 mg MDE Replacement
138380 Q3 2022 POLYISOBUTYLENE (1100000 MW) TRANSDERMAL SYSTEM 23mg MDE Replacement
138381 Q2 2022 POLYSORBATE 20 ORAL SUSPENSION 5.00 mg/ 1.00 ml MDE Replacement
138382 Q3 2022 POLYSORBATE 20 ORAL SUSPENSION 21mg MDE Replacement
138383 Q2 2022 POLYSORBATE 80 ORAL PASTE 0.92 mg/ 1.00 ml MDE Replacement
138384 Q3 2022 POLYSORBATE 80 ORAL PASTE 28mg MDE Replacement
138385 Q2 2022 POLYSORBATE 80 ORAL TABLET, EXTENDED RELEASE 8.00 mg MDE Replacement
138386 Q3 2022 POLYSORBATE 80 ORAL TABLET, EXTENDED RELEASE 8mg MDE Replacement
138387 Q2 2022 POLYSORBATE 80 RECTAL SOLUTION 0.10 %w/v MDE Replacement
138388 Q3 2022 POLYSORBATE 80 RECTAL SOLUTION 840mg MDE Replacement
138389 Q2 2022 POTASSIUM BICARBONATE ORAL POWDER, FOR SOLUTION 500.00 mg MDE Replacement
138390 Q3 2022 POTASSIUM BICARBONATE ORAL POWDER, FOR SOLUTION 1000mg MDE Replacement
138391 Q2 2022 POTASSIUM CARBONATE ORAL TABLET 25.00 mg MDE Replacement
138392 Q3 2022 POTASSIUM CARBONATE ORAL TABLET 60mg MDE Replacement
138393 Q2 2022 POTASSIUM SORBATE ORAL PASTE 1.60 mg/ 1.00 ml MDE Replacement
138394 Q3 2022 POTASSIUM SORBATE ORAL PASTE 48mg MDE Replacement
138395 Q2 2022 POTASSIUM SORBATE ORAL SUSPENSION 485 mg MDE Replacement
138396 Q3 2022 POTASSIUM SORBATE ORAL SUSPENSION 17ng MDE Replacement
138397 Q2 2022 POVIDONE K25 ORAL TABLET, FILM COATED 54.47 mg MDE Replacement
138398 Q3 2022 POVIDONE K25 ORAL TABLET, FILM COATED 163mg MDE Replacement
138399 Q2 2022 POVIDONE K30 ORAL CAPSULE, COATED, EXTENDED RELEASE 15.2 mg MDE Replacement
138400 Q3 2022 POVIDONE K30 ORAL CAPSULE, COATED, EXTENDED RELEASE 15mg MDE Replacement
138401 Q2 2022 POWDERED CELLULOSE ORAL SUSPENSION 100.00 mg/ 5.00 ml MDE Replacement
138402 Q3 2022 POWDERED CELLULOSE ORAL SUSPENSION 400mg MDE Replacement
138403 Q2 2022 PROPYLPARABEN TOPICAL CREAM, AUGMENTED 0.10 %w/w MDE Replacement
138404 Q3 2022 PROPYLPARABEN TOPICAL CREAM, AUGMENTED 2mg MDE Replacement
138405 Q2 2022 PROSOLV SMCC HD 90 ORAL TABLET, DELAYED RELEASE 195.37 mg MDE Replacement
138406 Q3 2022 PROSOLV SMCC HD 90 ORAL TABLET, DELAYED RELEASE 195mg MDE Replacement
138407 Q2 2022 PROSOLV SMCC HD 90 ORAL TABLET, FILM COATED 375.52 mg MDE Replacement
138408 Q3 2022 PROSOLV SMCC HD 90 ORAL TABLET, FILM COATED 376mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top